|
On May 2, Valley Children's Healthcare announced a historic donation of $15 million that will bring life-saving cancer treatment closer to home. The gift will expand the availability of bone marrow transplants and chimeric antigen receptor (CAR) T-cell therapy treatments to kids with cancer in the Central Valley, eliminating the need to refer these patients to the few facilities in Los Angeles or the Bay Area.
This anonymous donation is one of the largest single donations in the more than 70-year history of Valley Children's Healthcare. The gift will support not only the establishment and accreditation of the program, which will take three to four years, but also the operational funding of the program's first 10 years.
"With this amazing donation, Valley Children's joins the ranks of top children's hospitals in the nation that can offer these therapies, as well as being among the first to have access to future advances. This is life-saving advancement for our patients," says Dr. Vinod Balasa, medical director of Valley Children's Cancer and Blood Disorders Center.
CAR T-cell therapy is an advanced therapy that uses the body's natural immune system to fight cancer and infections. Autologous bone marrow transplants replace diseased bone marrow with other healthy marrow cells from their own body. The approach has been used for more than 50 years, and in a key CAR T-cell study in 2021, approximately 60% of children who underwent the therapy were cancer-free after 5 years.
As this wonderful news ripples throughout our community, we want to take time to thank you, fellow philanthropists. At Valley Children's we see it every day, in big ways like this, and in millions of smaller ways: it's the power of philanthropy to save lives.
|